Medical specialists from France tagged as investigators in clinical trials studying Pemphigoid, Bullous

Total 49 results

Agnès SPARSA, MD
Seen in:
- Limoges, Limoges university hospital
Trials:
- NCT00802243 (Sub-Investigator)
Conditions:
- Bullous Pemphigoid
Alyssa BENARFA, MD
Seen in:
- Libourne, CH de Libourne
Trials:
- NCT06148090 (Sub-Investigator)
Conditions:
- Pemphigoid, Bullous;
- Adrenal Insufficiency
Anne PHAM-LEDARD, MD, PhD
Seen in:
- Bordeaux, University Hospital of Bordeaux - Hospital Saint André
Trials:
- NCT06148090 (Principal Investigator)
Conditions:
- Pemphigoid, Bullous;
- Adrenal Insufficiency
Anne-Laure AJEIL
Seen in:
- Paris, Paris hospital Bretonneau (APHP)
Trials:
- NCT06291350 (Principal Investigator)
Conditions:
- Pemphigoid, Benign Mucous Membrane;
- Gingivitis Hyperplastic
Bernard Philippe
Seen in:
- Reims, CHU de Reims
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Billal TEDBIRT, MD
Seen in:
- Rouen, CHU de Rouen
Trials:
- NCT06148090 (Sub-Investigator)
Conditions:
- Pemphigoid, Bullous;
- Adrenal Insufficiency
Bruno Labeille
Seen in:
- Saint-Étienne, CHU SAINT-ETIENNE
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Carle PAUL, MD
Seen in:
- Toulouse, Toulouse University Hospital
Trials:
- NCT00802243 (Principal Investigator)
Conditions:
- Bullous Pemphigoid
Catherine Lok
Seen in:
- Amiens, CHU Amiens
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Catherine Picard-Dahan
Seen in:
- Paris, APHP Bichat
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Catherine Prost
Seen in:
- Paris, APHP Avicennes
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Christophe Bedane
Seen in:
- Limoges, CHU de Limoges
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Clemence LEPELLETIER-BEAUFOND, MD
Seen in:
- Paris, Hopital Saint Louis
Trials:
- NCT06148090 (Sub-Investigator)
Conditions:
- Pemphigoid, Bullous;
- Adrenal Insufficiency
Delaporte Emmanuel, PhD
Seen in:
- Bouches Du Rhône, Marseille, APHM, hôpital nord
Trials:
- NCT04563923 (Sub-Investigator)
Conditions:
- Bullous Pemphigoid
Denis Jullien
Seen in:
- Lyon, HCL
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Dereure Olivier, PhD
Seen in:
- Herault, Montpellier, CHU Montpellier, Dermatologie
- Occitanie, Montpellier, CHU de Montpellier
Trials:
- NCT05649683 (Sub-Investigator)
- NCT04563923 (Sub-Investigator)
Conditions:
- Melanoma (Skin);
- Bullous Pemphigoid
Emilie MIO BERTOLO, MD
Seen in:
- Limoges, CHU de Limoges
Trials:
- NCT06148090 (Sub-Investigator)
Conditions:
- Pemphigoid, Bullous;
- Adrenal Insufficiency
Emmanuel Delaporte
Seen in:
- Lille, CHU Lille
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Emmanuel Mahe
Seen in:
- Argenteuil, CH Argenteuil
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Emmanuelle TANCREDE-BOHIN, MD
Seen in:
- Paris, Hopital Saint Louis
Trials:
- NCT06148090 (Principal Investigator)
Conditions:
- Pemphigoid, Bullous;
- Adrenal Insufficiency
Gaelle Querreux
Seen in:
- Nantes, CHU Nantes
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Jean Marie BONNETBLANC, MD
Seen in:
- Limoges, Limoges university hospital
Trials:
- NCT00802243 (Sub-Investigator)
Conditions:
- Bullous Pemphigoid
Jean-David Bouaziz
Seen in:
- Paris cedex 10, GSK Investigational Site
- Paris, APHP Saint-Louis
- Paris, Cedex 10, Hôpital Saint-Louis
Trials:
- NCT05531565 (Principal Investigator)
- NCT03295383 (Principal Investigator)
- NCT05999799 (Principal Investigator)
Conditions:
Jean-Philippe BERNARD, MD
Seen in:
- Limoges, CHU de Limoges
Trials:
- NCT06148090 (Principal Investigator)
Conditions:
- Pemphigoid, Bullous;
- Adrenal Insufficiency
Jean-Philippe Lacour
Seen in:
- Nice, CHU Nice
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid
Julie BOUTEILLER, MD
Seen in:
- Rouen, CHU de Rouen
Trials:
- NCT06148090 (Sub-Investigator)
Conditions:
- Pemphigoid, Bullous;
- Adrenal Insufficiency
Julie CENDRAS, MD
Seen in:
- Limoges, Limoges university hospital
Trials:
- NCT00802243 (Sub-Investigator)
Conditions:
- Bullous Pemphigoid
Julien SENESCHAL, MD, PhD
Seen in:
- Bordeaux, University Hospital of Bordeaux - Hospital Saint André
Trials:
- NCT06148090 (Sub-Investigator)
Conditions:
- Pemphigoid, Bullous;
- Adrenal Insufficiency
Juliette ROCHEFORT
Seen in:
- Paris, Paris hospital Pitié Salpetrière (APHP)
Trials:
- NCT06291350 (Principal Investigator)
Conditions:
- Pemphigoid, Benign Mucous Membrane;
- Gingivitis Hyperplastic
Laurence Verneuil
Seen in:
- Caen, CHU Caen
Trials:
- NCT03295383 (Principal Investigator)
Conditions:
- Severe Forms of Mucous Membrane Pemphigoid

Clinical Trials on Pemphigoid, Bullous

Mayo Clinic
Eli Lilly and Company

Completed

Ixekizumab in the Treatment of Bullous Pemphigoid

Bullous Pemphigoid | Pemphigoid

United States
AKARI Therapeutics

Completed

rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects

Bullous Pemphigoid (BP)

Germany, Netherlands
University Hospital, Rouen

Not yet recruiting

Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid (IGA score)

Bullous Pemphigoid

France
Peking University First Hospital
West China Hospital; Ruijin Hospital; Second Xiangya Hospital of Central South... and other collaborators

Completed

Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid

Bullous Pemphigoid

China
Assistance Publique Hopitaux De Marseille

Unknown

Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?

Bullous Pemphigoid

France
University Hospital, Rouen
Société de Dermatologie Française

Unknown

Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid (RECOPB)

Bullous Pemphigoid

France
CHU de Reims

Completed

Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid (Cyto-PB)

Bullous Pemphigoid

France
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids

Bullous Pemphigoid

Japan
University of Iowa
Genentech, Inc.

Completed

Efficacy and Safety of Omalizumab in Bullous Pemphigoid

Bullous Pemphigoid

United States
University Hospital, Limoges

Unknown

Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid (ARABUL)

Bullous Pemphigoid

France

Medical specialists from France tagged as investigators in clinical trials studying Pemphigoid, Bullous

Clinical Trials on Pemphigoid, Bullous

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations